DXCM DexCom, Inc. - Common Stock
$90.75
Price · Aug 18, 2026
Fundamentals as of Jul 30, 2026
52W Range
$54–$92
97% of range
Analyst Rating
BUY
36 analysts
Price Target
$93
+3% upside
P/E (TTM)
43.5
ROE
31.4%
Net Profit Margin
17.9%
About DexCom, Inc. - Common Stock Company overview from Wikipedia
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Read more
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
History
Dexcom was founded in 1999 by Scott Glenn, John Burd, Lauren Otsuki, Ellen Preston and Bret Megargel. In 2006, Dexcom received U.S. Food and Drug Administration (FDA) approval and launched the Dexcom STS Continuous Glucose Monitoring System, which is a three-day sensor that provides up to 288 glucose measurements for every 24 hours. Dexcom received approval of the second-generation product, the Seven Continuous Glucose Monitoring System, in May 2007. This device improved on accuracy and extended use from three to seven days. In 2008, Dexcom announced two consumer development agreements with Insulet Corporation and Animas Corporation as well as a development agreement with Edwards Lifesciences for a continuous glucose monitor in the intensive care unit hospital environment.
During February 2009, Dexcom received approval for the Seven Plus Continuous Glucose Monitor, its new continuous glucose monitoring system, from the FDA. This product received a CE mark in November 2009. In 2013, development work for integration with Insulet was discontinued. Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its forthcoming G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. The G5 was approved in 2016 by the FDA for use as a standalone device, while the G6 gained approval in 2018.
Dexcom's first G-series CGM, the G4 Platinum, received a CE mark and FDA approval in 2012 for adults ages 18 and over. This device improved hypoglycemic accuracy by 30%. It also offered a longer range of transmission between the sensor and receiver, as well as a color LCD. The G4 Platinum was approved by the FDA for use in patients ages 2–17 in February 2014. Dexcom received FDA approval in January 2015 for the G4 Platinum with Share, which enabled the sharing of CGM data with up to five other people using the "Share" and "Follow" smartphone apps.
The Dexcom G5 was approved in August 2015 by the FDA for use as a standalone device, the G5 has Bluetooth integrated into its transmitter, enabling it to send data to a mobile device. This allows for use of the device without the standalone receiver. The Dexcom G5 received a CE mark in September 2015.
Dexcom went public in 2005 and is listed on the Nasdaq Global Select Market stock exchange under the ticker symbol DXCM. On April 20, 2020, Dexcom became a component of the Nasdaq-100, replacing American Airlines Group in the index.
The Dexcom G7 was approved in December 2022 by the FDA for use as a standalone device. The Dexcom G7 15-Day is the most accurate currently approved CGM in the U.S.
Awards and recognition
In October 2024, Time Magazine named Dexcom Stelo's over-the-counter glucose monitor one of the year's best inventions.
Partnerships
Dexcom entered into a partnership in 2015 with Google Life Sciences (which subsequently became Verily) to develop the Dexcom G7
Dexcom entered a non-exclusive agreement with Tandem Diabetes Care, Inc. in 2015 to allow the integration of its new G5 and G6 continuous glucose monitoring systems into Tandem's insulin pumps. Tandem Diabetes Care received FDA approval in December 2019 for Control-IQ, a closed-loop technology that uses Tandem's t:slim X2 insulin pump and the Dexcom G6 "to automatically increase, decrease, or stop the delivery of insulin in response to the glucose levels of people with Type 1 diabetes."
In June 2019, Dexcom announced a collaboration with Companion Medical to enable the exchange of CGM data from Dexcom with insulin data from InPen into both companies' software applications.
Dexcom entered into a partnership with Livongo, a digital chronic care management company, in January 2020 to share CGM data from the Dexcom G6 with Livongo's platform. This integration allowed Livongo to incorporate the CGM data along with other patient data.
In February 2020, Dexcom and Insulet Corporation signed a non-exclusive, global agreement to combine current and future Dexcom continuous glucose monitoring systems with Insulet's tubeless insulin delivery Pod into the Omnipod Horizon System for automated insulin delivery. This allowed the ability to adjust insulin doses based on Insulet's algorithm or through their smartphone.
The company also announced in March 2020 a partnership with Welldoc to integrate G6 CGM data with BlueStar, a digital platform for diabetes management.
In November 2024, Dexcom announced a "strategic partnership" and data exchange with Oura.
Venture capital arm
In early 2021, Dexcom launched Dexcom Ventures, a venture capital arm focused on emerging continuous glucose monitoring technologies and devices measuring the levels of other types of substances and analytes. In practice, Dexcom Ventures has also invested in cybersecurity platforms for the software used in medical devices.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
DXCM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$90.75
Market Cap
$35.02B
P/E (TTM)
43.5
EPS (TTM)
$2.09
Revenue (TTM)
$4.66B
Div Yield
—
ROE
31.4%
Debt/Equity
—
52W Range
$54 – $92
DXCM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$4.66B
2016-12-31
→
2025-12-31
EPS
$2.09
2017-12-31
→
2025-12-31
Free Cash Flow
$1.08B
2016-12-31
→
2025-12-31
Margins
17.9%
2018-12-31
→
2025-12-31
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
DXCM
Peer Median
P/E (TTM)
43.5
26.3
P/S (TTM)
7.5
4.4
P/B
12.8
5.3
Price / FCF
32.5
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
DXCM
Peer Median
Gross Margin
60.1%
63.1%
Operating Margin
19.6%
—
Net Profit Margin
17.9%
15.6%
ROA
13.0%
7.6%
ROE
31.4%
15.0%
ROIC
25.5%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
DXCM
Peer Median
Current Ratio
1.9
1.7
Quick Ratio
1.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
DXCM
Peer Median
Revenue YoY
15.6%
—
Revenue CAGR 3Y
17.0%
—
Revenue CAGR 5Y
19.3%
—
EPS YoY
47.2%
—
Net Income YoY
45.1%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
DXCM
Peer Median
DXCM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
36 analysts
- Strong Buy 15 41.7%
- Buy 16 44.4%
- Hold 5 13.9%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
25 analysts · 2026-08-14
Median
$93.00
Now
$90.75
Low
$79.00
High
$115.00
Median target
$93.00
+2.5%
Mean target
$93.44
+3.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.05%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $0.70 | $0.62 | 0.08% |
| March 31, 2026 | $0.56 | $0.48 | 0.08% |
| Dec. 31, 2025 | $0.56 | $0.48 | 0.08% |
| Sept. 30, 2025 | $0.61 | $0.58 | 0.03% |
| June 30, 2025 | $0.48 | $0.45 | 0.03% |
| March 31, 2025 | $0.32 | $0.33 | -0.01% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 18
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | · | · | |
| Cost of Revenue | $1.86B | $1.59B | $1.33B | $1.03B | $768M | $647M | $544M | $368M | $226M | $195M | $124M | $83M | |
| Gross Profit | $2.80B | $2.44B | $2.29B | $1.88B | $1.68B | $1.28B | $932M | $664M | $492M | $378M | $278M | $176M | |
| R&D Expense | $599M | $552M | $506M | $484M | $517M | $360M | $274M | $200M | $185M | $156M | $138M | $69M | |
| SG&A Expense | $1.29B | $1.29B | $1.19B | $1.01B | $810M | $618M | $516M | $433M | $349M | $286M | $198M | $128M | |
| Operating Expenses | $1.89B | $1.84B | $1.69B | $1.49B | $1.41B | $981M | $789M | $850M | $535M | $442M | $336M | $198M | |
| Operating Income | $912M | $600M | $598M | $391M | $266M | $300M | $142M | $-186M | $-42M | $-64M | $-57M | $-22M | |
| Interest Expense | · | · | $20M | $19M | $19M | $18M | $60M | $23M | $13M | $700.0K | $400.0K | $800.0K | |
| Interest Income | · | · | · | · | · | · | · | · | $3M | $400.0K | $0 | $0 | |
| Other Non-op | $177M | $109M | $113M | $-400.0K | $-9M | $16M | $26M | $2M | $7M | $-700.0K | $0 | $0 | |
| Pretax Income | $1.09B | $709M | $710M | $391M | $257M | $298M | $104M | $-126M | $-49M | $-65M | $-58M | $-22M | |
| Income Tax | $252M | $133M | $169M | $50M | $40M | $-252M | $3M | $600.0K | $2M | $700.0K | $100.0K | $100.0K | |
| Net Income | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| EPS (Basic) | $2.14 | $1.46 | $1.40 | $0.88 | $0.56 | $1.46 | $1.11 | $-1.44 | $-0.58 | · | · | · | |
| EPS (Diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 | $1.33 | $1.10 | $-1.44 | $-0.58 | · | · | · | |
| Shares (Basic) | 390,200,000 | 393,600,000 | 386,000,000 | 389,400,000 | 386,900,000 | 377,500,000 | 91,100,000 | 88,200,000 | 86,300,000 | · | · | · | |
| Shares (Diluted) | 405,500,000 | 412,700,000 | 425,500,000 | 427,500,000 | 428,800,000 | 420,400,000 | 92,300,000 | 88,200,000 | 86,300,000 | · | · | · | |
| EBITDA | $1.16B | $818M | $784M | $547M | $368M | $367M | $191M | $-157M | $-26M | $-49M | $-46M | $-13M |
Balance Sheet 26
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $918M | $606M | $566M | $642M | $1.05B | $818M | $446M | $1.14B | $442M | $94M | $86M | $72M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $93M | $23M | · | · | |
| Receivables | $1.22B | $1.01B | $974M | $713M | $514M | $428M | $286M | $227M | $134M | $102M | $74M | $42M | |
| Inventory | $629M | $543M | $560M | $307M | $357M | $235M | $120M | $71M | $45M | $45M | $35M | $16M | |
| Prepaid Expense | $189M | $174M | $168M | $193M | $82M | $54M | $30M | $16M | $17M | $9M | $7M | $4M | |
| Other Current Assets | $29M | $29M | $49M | $27M | $27M | · | · | · | · | · | · | · | |
| Current Assets | $4.03B | $4.30B | $4.43B | $3.67B | $3.68B | $3.42B | $1.97B | $1.70B | $745M | $280M | $231M | $146M | |
| PP&E (Net) | · | · | · | $1.06B | $802M | $515M | $321M | $183M | $146M | $109M | $55M | $31M | |
| PP&E (Gross) | · | · | · | $1.42B | $1.03B | $670M | $426M | $263M | $200M | $157M | $93M | $64M | |
| Accum. Depreciation | · | · | · | $363M | $232M | $154M | $105M | $80M | $55M | $47M | $38M | $33M | |
| Goodwill | $24M | $23M | $25M | $26M | $26M | $19M | $19M | $19M | $12M | $11M | $4M | $3M | |
| Intangibles | $71M | $103M | $134M | $173M | $32M | · | · | · | · | $200.0K | $2M | $3M | |
| Other Non-current Assets | $279M | $173M | $75M | $47M | $10M | $21M | $14M | $15M | $2M | $2M | $100.0K | $600.0K | |
| Total Assets | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Current Liabilities | $2.14B | $2.93B | $1.56B | $1.84B | $721M | $614M | $360M | $222M | $139M | $102M | $67M | $41M | |
| Capital Leases | $73M | $65M | $80M | $95M | $99M | $102M | $72M | $0 | · | · | · | · | |
| Deferred Tax | · | · | · | $5M | $6M | $0 | · | · | · | · | · | · | |
| Other Non-current Liabilities | $137M | $148M | $126M | $128M | $90M | $81M | $20M | $20M | $18M | $17M | $4M | $2M | |
| Total Liabilities | $3.59B | $4.38B | $4.20B | $3.26B | $2.89B | $2.46B | $1.51B | $1.25B | $485M | $119M | $71M | $44M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $5M | |
| Retained Earnings | $2.43B | $1.60B | $1.02B | $480M | $139M | $-78M | $-696M | $-799M | $-672M | $-621M | $-555M | $-498M | |
| Treasury Stock | $2.08B | $1.58B | $2.45B | $595M | $206M | $100M | $100M | $100M | $0 | · | · | · | |
| AOCI | $115M | $-8M | $-17M | $-12M | $500.0K | $3M | $2M | $2M | $-3M | $-1M | $-300.0K | $-100.0K | |
| Stockholders' Equity | $2.75B | $2.10B | $2.07B | $2.13B | $2.04B | $1.55B | $883M | $663M | $419M | $284M | $221M | $140M | |
| Liabilities + Equity | $6.34B | $6.48B | $6.26B | $5.39B | $4.93B | $4.29B | $2.40B | $1.92B | $904M | $403M | $292M | $185M | |
| Shares Outstanding | 384,800,000 | 390,700,000 | 385,400,000 | 386,300,000 | 388,000,000 | 384,400,000 | 366,400,000 | 90,000,000 | 87,000,000 | 84,600,000 | 81,700,000 | 77,300,000 |
Cash Flow 19
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $252M | $218M | $186M | $156M | $102M | $67M | $49M | $29M | $16M | $15M | $11M | $8M | |
| Stock-based Comp | $160M | $170M | $151M | $126M | $113M | $119M | $103M | $102M | $106M | $111M | $83M | $50M | |
| Deferred Tax | $182M | $-44M | $-55M | $-22M | $16M | $-260M | $200.0K | $-2M | $0 | $-200.0K | $0 | $0 | |
| Amort. of Intangibles | $4M | $7M | $8M | $8M | $4M | $2M | · | · | · | $700.0K | $500.0K | $600.0K | |
| Restructuring | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Other Non-cash | $11M | $69M | $-75M | $68M | $77M | $73M | $62M | $122M | $20M | $-4M | $13M | $-12M | |
| Operating Cash Flow | $1.44B | $990M | $748M | $670M | $442M | $476M | $314M | $123M | $92M | $56M | $49M | $24M | |
| CapEx | $364M | $359M | $237M | $365M | $389M | $199M | $180M | $67M | $66M | $56M | $33M | $16M | |
| Investing Cash Flow | $536M | $-208M | $-507M | $-522M | $-216M | $-1.02B | $-1.02B | $-140M | $-144M | $-56M | $-52M | $-17M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | $-2M | $-2M | $-2M | |
| Stock Issued | $28M | $28M | $27M | $22M | $20M | $15M | $12M | $11M | $10M | $10M | $19M | $24M | |
| Stock Repurchased | $500M | $750M | $689M | $558M | $0 | $0 | $0 | $100M | $0 | $0 | · | · | |
| Net Stock Activity | $-472M | $-722M | $-662M | $-535M | $20M | $15M | $12M | $-89M | $10M | $10M | $19M | $24M | |
| Financing Cash Flow | $-1.69B | $-735M | $-319M | $-552M | $10M | $912M | $11M | $710M | $399M | $8M | $17M | $22M | |
| Net Change in Cash | $312M | $40M | $-76M | $-410M | $235M | $372M | $-691M | $696M | $347M | $8M | $14M | $29M | |
| Taxes Paid | $94M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M | $277M | $134M | $56M | $26M | $500.0K | $16M | $7M | |
| Levered FCF | · | · | $496M | $288M | $-36M | $91M | $76M | $33M | $13M | $-207.6K | $15M | $7M |
Profitability 8
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% | 66.4% | 63.1% | 64.4% | · | · | · | · | |
| Operating Margin | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% | 15.5% | 9.6% | -18.1% | · | · | · | · | |
| Net Margin | 17.9% | 14.3% | 14.9% | 11.7% | 6.3% | 25.6% | 6.9% | -12.3% | · | · | · | · | |
| Pretax Margin | 23.4% | 17.6% | 19.6% | 13.4% | 7.1% | 11.7% | 7.1% | -12.3% | · | · | · | · | |
| EBITDA Margin | 25.0% | 20.3% | 21.6% | 18.8% | 15.0% | 19.0% | 12.9% | -15.2% | · | · | · | · | |
| ROA | 13.0% | 9.0% | 9.3% | 6.6% | 3.4% | 14.8% | 4.7% | -9.0% | -7.7% | -18.9% | -24.2% | -14.6% | |
| ROE | 31.4% | 28.2% | 25.0% | 17.2% | 7.4% | 29.7% | 12.3% | -20.7% | -14.3% | -26.0% | -31.9% | -20.0% | |
| ROIC | 25.5% | 23.2% | 22.0% | 16.0% | 10.5% | 36.0% | 15.6% | -28.2% | -10.5% | -22.8% | -25.9% | -15.4% |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 | 5.6 | 5.5 | 7.6 | 5.4 | 2.7 | 3.5 | 3.6 | |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 | 2.0 | 2.0 | 6.1 | 4.8 | 2.1 | 2.4 | 1.8 | |
| Interest Coverage | · | · | 29.4 | 21.0 | 2.6 | 3.5 | 2.4 | -8.2 | -3.3 | -91.3 | -142.8 | -26.9 |
Efficiency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Inventory Turnover | 3.2 | 2.9 | 3.1 | 3.1 | 2.6 | 3.6 | 5.7 | 6.3 | 5.0 | 4.8 | 4.8 | 6.6 | |
| Receivables Turnover | 4.2 | 4.1 | 4.3 | 4.7 | 5.2 | 5.4 | 5.8 | 5.7 | · | · | · | · |
Growth Rates 9
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 15.6% | 11.3% | 24.5% | 18.8% | 27.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 17.0% | 18.1% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 47.2% | 9.2% | 58.5% | 54.7% | -60.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 36.6% | 38.9% | -0.76% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 45.1% | 6.4% | 58.7% | 57.3% | -60.5% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 34.8% | 38.5% | -0.50% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 8.8% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B | $1.93B | $1.48B | $1.03B | $718M | $573M | $402M | $259M | |
| Net Income TTM | $836M | $576M | $542M | $341M | $217M | $550M | $101M | $-127M | $-50M | $-66M | $-58M | $-22M | |
| Market Cap | $25.54B | $30.38B | $47.82B | $43.74B | $13.02B | $8.88B | $5.01B | $2.70B | $1.25B | $1.26B | $1.67B | $1.06B | |
| P/E | 31.8 | 54.8 | 95.5 | 138.1 | 253.3 | 69.5 | 49.7 | -20.8 | -24.7 | · | · | · | |
| P/S | 5.5 | 7.5 | 13.2 | 15.0 | 5.3 | 4.6 | 3.4 | 2.6 | 1.7 | 2.2 | 4.2 | 4.1 | |
| P/B | 9.3 | 14.5 | 23.1 | 20.5 | 5.8 | 4.9 | 5.7 | 4.1 | 3.0 | 4.4 | 7.6 | 7.6 | |
| P / Tangible Book | 9.6 | 15.4 | 25.1 | 22.6 | 6.6 | 5.8 | · | · | · | · | · | · | |
| P / Cash Flow | 17.7 | 30.7 | 63.9 | 65.3 | 29.4 | 18.7 | 15.9 | 21.9 | 13.6 | 22.5 | 34.1 | 45.1 | |
| P / FCF | 23.7 | 48.2 | 93.4 | 143.6 | 244.3 | 32.1 | 37.2 | 48.0 | 48.0 | 2525.3 | 106.5 | 143.8 | |
| Earnings Yield | 3.1% | 1.8% | 1.1% | 0.72% | 0.39% | 1.4% | 2.0% | -4.8% | -4.0% | · | · | · |
Income Statement 17
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.31B | $1.19B | $1.26B | $1.21B | $1.16B | $1.04B | $1.11B | $994M | $1.00B | $921M | $1.03B | $975M | $871M | $742M | $815M | $770M | |
| Cost of Revenue | $478M | $442M | $467M | $478M | $468M | $447M | $458M | $400M | $378M | $359M | $378M | $352M | $325M | $279M | $274M | $275M | |
| Gross Profit | $830M | $750M | $793M | $731M | $689M | $589M | $656M | $594M | $627M | $562M | $657M | $623M | $546M | $463M | $541M | $494M | |
| R&D Expense | $153M | $145M | $148M | $158M | $148M | $145M | $140M | $135M | $136M | $142M | $136M | $131M | $119M | $119M | $116M | $110M | |
| SG&A Expense | $359M | $350M | $322M | $331M | $328M | $310M | $327M | $306M | $333M | $319M | $304M | $286M | $299M | $296M | $305M | $235M | |
| Operating Expenses | $512M | $495M | $470M | $489M | $476M | $455M | $467M | $442M | $469M | $461M | $440M | $418M | $418M | $415M | $416M | $347M | |
| Operating Income | $318M | $255M | $323M | $242M | $213M | $134M | $189M | $152M | $158M | $101M | $217M | $206M | $128M | $47M | $125M | $148M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $5M | · | $5M | $6M | $5M | · | $5M | |
| Other Non-op | $-800.0K | $14M | $18M | $110M | $28M | $21M | $22M | $25M | $30M | $31M | $29M | $35M | $31M | $17M | $-1M | $-1M | |
| Pretax Income | $318M | $270M | $341M | $352M | $241M | $154M | $211M | $177M | $188M | $132M | $246M | $240M | $159M | $64M | $133M | $146M | |
| Income Tax | $68M | $70M | $73M | $68M | $61M | $49M | $60M | $43M | $44M | $-14M | $-10M | $120M | $43M | $16M | $41M | $45M | |
| Net Income | $249M | $200M | $267M | $284M | $180M | $105M | $152M | $135M | $144M | $146M | $256M | $121M | $116M | $49M | $92M | $101M | |
| EPS (Basic) | $0.65 | $0.52 | $0.68 | $0.73 | $0.46 | $0.27 | $0.38 | $0.34 | $0.36 | $0.38 | $0.66 | $0.31 | $0.30 | $0.13 | $0.24 | $0.26 | |
| EPS (Diluted) | $0.64 | $0.51 | $0.67 | $0.70 | $0.45 | $0.27 | $0.37 | $0.34 | $0.35 | $0.36 | $0.61 | $0.29 | $0.28 | $0.12 | $0.23 | $0.24 | |
| Shares (Basic) | 382,200,000 | 385,100,000 | -784,100,000 | 391,100,000 | 392,100,000 | 391,100,000 | -790,000,000 | 394,200,000 | 399,200,000 | 390,200,000 | -774,000,000 | 386,600,000 | 386,700,000 | 386,700,000 | -781,800,000 | 389,800,000 | |
| Shares (Diluted) | 390,100,000 | 393,600,000 | -817,600,000 | 407,400,000 | 408,200,000 | 407,500,000 | -831,000,000 | 410,200,000 | 416,800,000 | 416,700,000 | -851,300,000 | 426,800,000 | 431,500,000 | 418,500,000 | -848,400,000 | 425,800,000 | |
| EBITDA | $386M | $322M | · | $306M | $276M | $194M | · | $152M | $158M | $154M | · | $206M | $128M | $89M | · | $148M |
Balance Sheet 24
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.12B | $918M | $1.84B | $1.16B | $905M | $606M | $621M | $939M | $851M | $566M | $644M | $1.19B | $623M | $642M | $698M | |
| Receivables | $1.26B | $1.09B | $1.22B | $1.11B | $1.35B | $1.16B | $1.01B | $1.00B | $945M | $979M | · | $786M | $751M | $637M | · | $564M | |
| Inventory | $726M | $694M | $629M | $604M | $571M | $538M | $543M | $586M | $570M | $589M | · | $499M | $421M | $366M | · | $311M | |
| Prepaid Expense | $156M | $134M | $189M | $184M | $181M | $159M | $174M | $182M | $212M | $156M | · | $174M | $195M | $198M | · | $152M | |
| Other Current Assets | $37M | $30M | $29M | $34M | $46M | $43M | $29M | $48M | $48M | $40M | · | $41M | $58M | $43M | · | $28M | |
| Current Assets | $4.09B | $4.33B | $4.03B | $5.22B | $5.03B | $4.55B | $4.30B | $4.26B | $4.85B | $4.62B | · | $4.70B | $5.00B | $3.77B | · | $3.40B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.08B | · | $1.00B | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.47B | · | $1.34B | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | $394M | · | $338M | |
| Goodwill | $24M | $24M | $24M | $24M | $24M | $23M | $23M | $24M | $23M | $23M | · | $25M | $26M | $26M | · | $25M | |
| Intangibles | $102M | $63M | $71M | $79M | $87M | $95M | $103M | $106M | $114M | $123M | · | $144M | $154M | $164M | · | $24M | |
| Other Non-current Assets | $274M | $286M | $279M | $276M | $176M | $168M | $173M | $88M | $83M | $78M | · | $74M | $67M | $57M | · | $34M | |
| Total Assets | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Current Liabilities | $2.36B | $2.22B | $2.14B | $3.34B | $3.31B | $3.04B | $2.93B | $1.73B | $1.72B | $1.59B | · | $1.68B | $2.07B | $1.86B | · | $900M | |
| Capital Leases | $83M | $69M | $73M | $51M | $55M | $60M | $65M | $71M | $77M | $76M | · | $83M | $87M | $90M | · | $82M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $151M | $142M | $137M | $147M | $152M | $150M | $148M | $130M | $128M | $129M | · | $134M | $133M | $130M | · | $123M | |
| Total Liabilities | $3.83B | $3.68B | $3.59B | $4.77B | $4.75B | $4.49B | $4.38B | $4.37B | $4.36B | $4.24B | · | $4.33B | $4.72B | $3.28B | · | $3.07B | |
| Retained Earnings | $2.88B | $2.63B | $2.43B | $2.17B | $1.88B | $1.70B | $1.60B | $1.45B | $1.31B | $1.17B | · | $765M | $644M | $528M | · | $388M | |
| Treasury Stock | $2.73B | $2.12B | $2.08B | $1.77B | $1.58B | $1.58B | $1.58B | $1.58B | $832M | $1.39B | · | $2.08B | $784M | $595M | · | $595M | |
| AOCI | $90M | $106M | $115M | $82M | $84M | $2M | $-8M | $63M | $-38M | $-37M | · | $-36M | $-29M | $-6M | · | $-41M | |
| Stockholders' Equity | $2.62B | $2.96B | $2.75B | $2.73B | $2.57B | $2.27B | $2.10B | $1.98B | $2.43B | $2.25B | $2.07B | $2.27B | $2.10B | $2.23B | $2.13B | $1.82B | |
| Liabilities + Equity | $6.46B | $6.63B | $6.34B | $7.50B | $7.33B | $6.75B | $6.48B | $6.35B | $6.80B | $6.48B | · | $6.60B | $6.82B | $5.52B | · | $4.90B | |
| Shares Outstanding | 377,400,000 | 385,900,000 | 384,800,000 | 390,000,000 | 392,200,000 | 392,100,000 | 390,700,000 | 390,600,000 | 400,700,000 | 396,100,000 | 385,400,000 | 386,400,000 | 386,100,000 | 387,600,000 | 386,300,000 | 386,200,000 |
Cash Flow 15
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $68M | $67M | $65M | $64M | $63M | $60M | $58M | $55M | $52M | $52M | $52M | $48M | $44M | $42M | $36M | $39M | |
| Stock-based Comp | $39M | $43M | $35M | $45M | $45M | $34M | $43M | $43M | $45M | $39M | $37M | $39M | $40M | $35M | $34M | $31M | |
| Deferred Tax | $-300.0K | $300.0K | $79M | $118M | $-9M | $-6M | $24M | $-12M | $-15M | $-42M | $82M | $-85M | $-42M | $-9M | $32M | $-34M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-cash | · | $215M | · | · | · | $-10M | · | · | · | $13M | · | · | · | $39M | · | · | |
| Operating Cash Flow | $269M | $526M | $294M | $660M | $303M | $184M | $301M | $200M | $279M | $209M | $134M | $269M | $190M | $155M | $132M | $293M | |
| CapEx | $85M | $77M | $102M | $80M | $94M | $87M | $125M | $111M | $66M | $57M | $52M | $50M | $59M | $75M | $64M | $108M | |
| Investing Cash Flow | $330M | $-298M | $307M | $193M | $-64M | $100M | $-304M | $210M | $-189M | $75M | $415M | $-180M | $-556M | $-187M | $-194M | $229M | |
| Stock Issued | $0 | $13M | $0 | $14M | $0 | $14M | $0 | $15M | $0 | $13M | $0 | $14M | $0 | $12M | $0 | $12M | |
| Stock Repurchased | · | · | $313M | $187M | · | · | $0 | $750M | · | · | $500M | $0 | · | · | $0 | $558M | |
| Net Stock Activity | · | $13M | · | · | · | $14M | · | · | · | $13M | · | · | · | $12M | · | · | |
| Financing Cash Flow | $-607M | $-25M | $-1.52B | $-175M | $-2M | $12M | $-2M | $-736M | $-1M | $5M | $-632M | $-637M | $940M | $11M | $-1M | $-552M | |
| Net Change in Cash | $-13M | $199M | $-918M | $677M | $254M | $299M | $-15M | $-318M | $88M | $285M | $-77M | $-551M | $572M | $-19M | $-56M | $-37M | |
| Free Cash Flow | · | $449M | · | · | · | $97M | · | · | · | $152M | · | · | · | $81M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $147M | · | · | · | $77M | · | · |
Profitability 8
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 63.4% | 62.9% | · | 60.5% | 59.5% | 56.9% | · | 59.7% | 62.4% | 61.0% | · | 63.9% | 62.7% | 62.4% | · | 64.2% | |
| Operating Margin | 24.3% | 21.4% | · | 20.1% | 18.4% | 12.9% | · | 15.3% | 15.7% | 11.0% | · | 21.1% | 14.7% | 6.4% | · | 19.2% | |
| Net Margin | 19.0% | 16.7% | · | 23.5% | 15.5% | 10.2% | · | 13.5% | 14.3% | 15.9% | · | 12.4% | 13.3% | 6.6% | · | 13.2% | |
| Pretax Margin | 24.3% | 22.6% | · | 29.1% | 20.8% | 14.9% | · | 17.8% | 18.7% | 14.4% | · | 24.7% | 18.3% | 8.7% | · | 19.0% | |
| EBITDA Margin | 29.5% | 27.1% | · | 25.3% | 23.8% | 18.7% | · | 15.3% | 15.7% | 16.7% | · | 21.1% | 14.7% | 12.0% | · | 19.2% | |
| ROA | 3.6% | 3.0% | · | 4.1% | 2.5% | 1.6% | · | 2.1% | 2.1% | 2.4% | · | 2.1% | 1.9% | 0.92% | · | 2.1% | |
| ROE | 9.6% | 7.6% | · | 12.1% | 7.2% | 4.7% | · | 6.3% | 6.3% | 6.5% | · | 5.9% | 5.3% | 2.2% | · | 5.1% | |
| ROIC | 9.5% | 6.4% | · | 7.2% | 6.2% | 4.0% | · | 5.8% | 5.0% | 5.0% | · | 4.5% | 4.4% | 1.6% | · | 5.6% |
Liquidity & Solvency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.9 | · | 1.6 | 1.5 | 1.5 | · | 2.5 | 2.8 | 2.9 | · | 2.8 | 2.4 | 2.0 | · | 3.8 | |
| Quick Ratio | 1.0 | 1.0 | · | 0.9 | 0.8 | 0.7 | · | 0.9 | 1.1 | 1.1 | · | 0.9 | 0.9 | 0.7 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 22.0 | · | 41.9 | 21.7 | 10.3 | · | 32.1 |
Efficiency 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.1 | 0.2 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | |
| Inventory Turnover | 0.7 | 0.7 | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.8 | · | 0.8 | |
| Receivables Turnover | 1.0 | 1.1 | · | 1.1 | 1.0 | 1.0 | · | 1.1 | 1.2 | 1.1 | · | 1.4 | 1.3 | 1.3 | · | 1.4 |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.87B | $4.59B | · | $4.40B | $4.19B | $3.96B | · | $3.89B | $3.77B | $3.51B | · | $3.36B | $3.08B | $2.84B | · | $2.74B | |
| Net Income TTM | $912M | $768M | · | $704M | $563M | $530M | · | $545M | $526M | $432M | · | $386M | $317M | $298M | · | $337M | |
| Market Cap | $25.42B | $24.23B | · | $26.24B | $34.24B | $26.78B | · | $26.19B | $45.43B | $54.94B | · | $36.05B | $49.62B | $45.03B | · | $31.10B | |
| P/E | 29.3 | 32.5 | · | 38.2 | 61.9 | 51.7 | · | 50.0 | 88.6 | 132.1 | · | 100.3 | 169.1 | 163.6 | · | 100.7 | |
| P/S | 5.2 | 5.3 | · | 6.0 | 8.2 | 6.8 | · | 6.7 | 12.0 | 15.7 | · | 10.7 | 16.1 | 15.9 | · | 11.3 | |
| P/B | 9.7 | 8.2 | · | 9.6 | 13.3 | 11.8 | · | 13.2 | 18.7 | 24.5 | · | 15.9 | 23.6 | 20.2 | · | 17.0 | |
| P / Tangible Book | 10.2 | 8.4 | · | 10.0 | 13.9 | 12.5 | · | 14.2 | 19.8 | 26.2 | · | 17.2 | 25.8 | 22.0 | · | 17.5 | |
| P / Cash Flow | · | 46.1 | · | · | · | 145.7 | · | · | · | 262.6 | · | · | · | 289.8 | · | · | |
| P / FCF | · | 54.0 | · | · | · | 276.6 | · | · | · | 360.7 | · | · | · | 558.0 | · | · | |
| Earnings Yield | 3.4% | 3.1% | · | 2.6% | 1.6% | 1.9% | · | 2.0% | 1.1% | 0.76% | · | 1.0% | 0.59% | 0.61% | · | 0.99% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $4.66B | $4.03B | $3.62B | $2.91B | $2.45B |
| Gross Margin % | 60.1% | 60.5% | 63.2% | 64.7% | 68.6% |
| Operating Margin % | 19.6% | 14.9% | 16.5% | 13.4% | 10.9% |
| Net Income | $836M | $576M | $542M | $341M | $217M |
| Diluted EPS | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.5 | 2.8 | 2.0 | 5.1 |
| Quick Ratio | 1.0 | 0.5 | 1.0 | 0.7 | 2.2 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $1.08B | $631M | $512M | $305M | $53M |
Latest News Recent headlines mentioning this company
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 1,087 filers · $16.0B total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 131 (-28 vs prior Q) | 96 (+4 vs prior Q) | 386 (+17 vs prior Q) | 352 (+6 vs prior Q) | +42.0M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1,697,876,797 | 25,209,752 | 10.61% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,323,867,969 | 19,656,540 | 8.27% | Shares |
| STATE STREET CORP | $1,237,947,284 | 18,380,806 | 7.73% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $751,533,926 | 11,199,611 | 4.70% | Shares |
| ALLIANCEBERNSTEIN L.P. | $734,346,085 | 11,693,409 | 4.59% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $545,031,559 | 8,092,525 | 3.41% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $462,914,937 | 6,873,273 | 2.89% | Shares |
| NORGES BANK | $462,565,862 | 6,868,090 | 2.89% | Shares |
| Castle Hook Partners LP | $260,667,534 | 3,870,342 | 1.63% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $231,614,091 | 3,438,962 | 1.45% | Shares |
| AMERICAN CENTURY COMPANIES INC | $206,860,340 | 3,071,423 | 1.29% | Shares |
| JANUS HENDERSON GROUP PLC | $162,720,013 | 2,591,083 | 1.02% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $152,790,681 | 2,268,607 | 0.95% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $149,327,006 | 2,217,179 | 0.93% | Shares |
| Employees Provident Fund Board | $147,498,453 | 2,190,029 | 0.92% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $129,989,908 | 2,069,903 | 0.81% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $114,711,656 | 1,703,218 | 0.72% | Shares |
| BLAIR WILLIAM & CO/IL | $112,182,565 | 1,665,665 | 0.70% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $109,834,111 | 1,630,796 | 0.69% | Shares |
| RAYMOND JAMES FINANCIAL INC | $102,869,971 | 1,527,394 | 0.64% | Shares |
| BANK OF AMERICA CORP /DE/ | $97,103,277 | 1,441,771 | 0.61% | Shares |
| AMERIPRISE FINANCIAL INC | $93,336,259 | 1,385,802 | 0.58% | Shares |
| VICTORY CAPITAL MANAGEMENT INC | $92,130,221 | 1,367,932 | 0.58% | Shares |
| DSM CAPITAL PARTNERS LLC | $91,537,742 | 1,359,135 | 0.57% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $89,939,931 | 1,335,411 | 0.56% | Shares |
| ROYAL BANK OF CANADA | $88,321,000 | 1,311,368 | 0.55% | Shares |
| GOLDMAN SACHS GROUP INC | $87,360,493 | 1,297,112 | 0.55% | Shares |
| CI INVESTMENTS INC. | $86,724,103 | 1,287,663 | 0.54% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $85,826,193 | 1,274,331 | 0.54% | Shares |
| BANK OF NOVA SCOTIA | $85,283,937 | 1,266,285 | 0.53% | Shares |
| DNB Asset Management AS | $84,543,377 | 1,255,284 | 0.53% | Shares |
| Nearwater Capital Markets, Ltd | $84,187,500 | 1,250,000 | 0.53% | Shares |
| Stephens Investment Management Group LLC | $81,126,645 | 1,204,553 | 0.51% | Shares |
| Swedbank AB | $78,528,215 | 1,165,972 | 0.49% | Shares |
| BlackRock, Inc. | $77,389,460 | 1,149,064 | 0.48% | Shares |
| FMR LLC | $77,274,023 | 1,147,350 | 0.48% | Shares |
| CITADEL ADVISORS LLC | $75,864,589 | 1,126,423 | 0.47% | Shares |
| FIRST TRUST ADVISORS LP | $74,838,523 | 1,111,188 | 0.47% | Shares |
| HSBC HOLDINGS PLC | $73,861,872 | 1,080,800 | 0.46% | Call option |
| Swiss National Bank | $73,108,425 | 1,085,500 | 0.46% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $71,040,241 | 1,054,792 | 0.44% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $67,343,265 | 999,900 | 0.42% | Shares |
| CITADEL ADVISORS LLC | $64,656,000 | 960,000 | 0.40% | Put option |
| Legal & General Group Plc | $64,638,083 | 959,734 | 0.40% | Shares |
| Sumitomo Mitsui Trust Group, Inc. | $64,478,600 | 957,366 | 0.40% | Shares |
| BAILLIE GIFFORD & CO | $63,928,755 | 949,202 | 0.40% | Shares |
| CIBC Bancorp USA Inc. | $62,958,645 | 932,286 | 0.39% | Shares |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $61,865,555 | 918,568 | 0.39% | Shares |
| PRINCIPAL FINANCIAL GROUP INC | $59,044,465 | 876,681 | 0.37% | Shares |
| Chicago Capital, LLC | $58,393,062 | 867,009 | 0.36% | Shares |
| Fisher Funds Management LTD | $56,637,983 | 840,950 | 0.35% | Shares |
| Vanguard Global Advisers, LLC | $56,107,871 | 833,079 | 0.35% | Shares |
| JANE STREET GROUP, LLC | $56,062,140 | 832,400 | 0.35% | Call option |
| Bellevue Group AG | $55,394,634 | 822,489 | 0.35% | Shares |
| Tri Locum Partners LP | $55,259,261 | 820,479 | 0.35% | Shares |
| RHUMBLINE ADVISERS | $51,735,803 | 768,165 | 0.32% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $51,168,667 | 759,743 | 0.32% | Shares |
| UBS Group AG | $51,066,858 | 758,231 | 0.32% | Shares |
| Allianz Asset Management GmbH | $50,820,963 | 809,251 | 0.32% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $50,518,000 | 750,088 | 0.32% | Shares |
| BARCLAYS PLC | $50,351,331 | 747,607 | 0.31% | Shares |
| VANGUARD ASSET MANAGEMENT, Ltd | $49,968,851 | 741,928 | 0.31% | Shares |
| TWO SIGMA ADVISERS, LP | $49,649,804 | 748,076 | 0.31% | Shares |
| Smith Group Asset Management, LLC | $47,235,720 | 701,347 | 0.30% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $46,761,576 | 694,307 | 0.29% | Shares |
| Assenagon Asset Management S.A. | $46,716,317 | 693,635 | 0.29% | Shares |
| NEUBERGER BERMAN GROUP LLC | $46,117,886 | 684,750 | 0.29% | Shares |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $44,760,810 | 664,600 | 0.28% | Shares |
| PEREGRINE CAPITAL MANAGEMENT LLC | $44,759,530 | 664,581 | 0.28% | Shares |
| Capital International Investors | $44,585,633 | 661,999 | 0.28% | Shares |
| CAPITAL FUND MANAGEMENT S.A. | $44,543,875 | 661,379 | 0.28% | Shares |
| Pictet Asset Management Holding SA | $44,534,379 | 661,238 | 0.28% | Shares |
| National Pension Service | $44,471,811 | 660,309 | 0.28% | Shares |
| California Public Employees Retirement System | $42,988,899 | 638,291 | 0.27% | Shares |
| Korea Investment CORP | $42,608,237 | 632,639 | 0.27% | Shares |
| ING GROEP NV | $41,334,513 | 613,727 | 0.26% | Shares |
| Susquehanna Portfolio Strategies, LLC | $41,226,753 | 612,127 | 0.26% | Shares |
| MIG Capital, LLC | $40,190,154 | 605,547 | 0.25% | Shares |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $39,472,718 | 584,004 | 0.25% | Shares |
| Quantinno Capital Management LP | $39,303,248 | 583,567 | 0.25% | Shares |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $36,898,831 | 587,561 | 0.23% | Shares |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $36,855,267 | 547,220 | 0.23% | Shares |
| FACTORY MUTUAL INSURANCE CO | $36,222,851 | 537,830 | 0.23% | Shares |
| Woodline Partners LP | $36,146,880 | 536,702 | 0.23% | Shares |
| Parkman Healthcare Partners LLC | $36,016,557 | 534,767 | 0.23% | Shares |
| MARSHALL WACE, LLP | $35,884,349 | 532,804 | 0.22% | Shares |
| Walleye Trading LLC | $35,823,465 | 531,900 | 0.22% | Call option |
| EVENTIDE ASSET MANAGEMENT, LLC | $33,574,377 | 498,202 | 0.21% | Shares |
| Blue Sparrow, LLC /DE | $32,368,410 | 480,600 | 0.20% | Shares |
| Trexquant Investment LP | $31,938,380 | 474,215 | 0.20% | Shares |
| Cubist Systematic Strategies, LLC | $31,905,647 | 474,151 | 0.20% | Shares |
| UBS Group AG | $31,896,960 | 473,600 | 0.20% | Put option |
| Mitsubishi UFJ Trust & Banking Corp | $31,227,164 | 463,655 | 0.20% | Shares |
| USS Investment Management Ltd | $30,910,132 | 459,050 | 0.19% | Shares |
| OFI INVEST ASSET MANAGEMENT | $29,454,211 | 500,000 | 0.18% | Shares |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $29,397,534 | 436,489 | 0.18% | Shares |
| ProShare Advisors LLC | $28,566,636 | 424,152 | 0.18% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $28,528,135 | 427,840 | 0.18% | Shares |
| SIRIOS CAPITAL MANAGEMENT L P | $28,315,152 | 420,418 | 0.18% | Shares |
| Bridgewater Associates, LP | $27,002,568 | 400,929 | 0.17% | Shares |
Company insiders 60 insiders · 36 officers · 23 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jacob Steven Leach | President, CEO, and Director | May 22, 2026 F | 420,359 | 2 | 0 | $1,001,761 |
| Andrew P Rasdal | President & CEO | May 2, 2006 M | 2,944 | 0 | 0 | $0 |
| Jess Roper | SVP, CFO | March 22, 2017 S | 8,452 | 0 | 0 | $0 |
| Steven J Kemper | Chief Financial Officer | May 15, 2007 A | 26,255 | 0 | 0 | $0 |
| Quentin S. Blackford | Chief Operating Officer | Sept. 10, 2021 S | 19,280 | 0 | 0 | $0 |
| Kevin R Sayer | Executive Chair | July 20, 2026 S | 328,970 | 0 | 3 | $-5,895,098 |
| Jon Coleman | EVP, Chief Commercial Officer | June 4, 2026 S | 95,450 | 0 | 2 | $-722,628 |
| Sadie Stern | EVP Chief People & Culture Off | May 22, 2026 F | 130,059 | 0 | 1 | $-117,280 |
| Jereme M Sylvain | EVP, Chief Financal Officer | May 22, 2026 F | 151,841 | 0 | 1 | $-357,796 |
| Matthew Vincent Dolan | EVP, Strategy & Corporate Dev | Jan. 29, 2025 S | 42,044 | 0 | 0 | $0 |
| Teri L Lawver | EVP Chief Commercial Officer | March 12, 2024 S | 66,641 | 0 | 0 | $0 |
| Paul R Flynn | EVP Global Revenue | Dec. 18, 2023 D | 48,949 | 0 | 0 | $0 |
| Barry J. Regan | EVP Operations | Dec. 18, 2023 D | 58,469 | 0 | 0 | $0 |
| Steven Robert Pacelli | EVP Managing Director Dexcom V | Nov. 24, 2023 S | 124,775 | 0 | 0 | $0 |
| Girish Naganathan | EVP Chief Technology Officer | Nov. 9, 2023 S | 47,725 | 0 | 0 | $0 |
| Shelly Ramasamy Selvaraj | SVP Chief Information Officer | Sept. 11, 2023 D | 48,453 | 0 | 0 | $0 |
| Donald Abbey | EVP Global Business Services I | March 10, 2023 D | 208,023 | 0 | 0 | $0 |
| Andrew K Balo | EVP Regulatory Strategy Clinic | March 10, 2023 D | 50,908 | 0 | 0 | $0 |
| Chad Patterson | EVP Global Marketing | May 9, 2022 S | 13,675 | 0 | 0 | $0 |
| Sumi Shrishrimal | SVP Chief Risk Officer | March 9, 2022 D | 13,789 | 0 | 0 | $0 |
| Patrick Michael Murphy | EVP, Chief Legal Officer | Sept. 9, 2021 S | 16,254 | 0 | 0 | $0 |
| Richard Doubleday | EVP Chief Commercial Officer | March 23, 2021 S | 6,654 | 0 | 0 | $0 |
| Jeffrey Moy | EVP Operations | Sept. 9, 2020 D | 34,784 | 0 | 0 | $0 |
| Heather S Ace | SVP Human Resources | March 11, 2020 S | 38,584 | 0 | 0 | $0 |
| Terrance H Gregg | Executive Chairman | July 16, 2018 S | 50,882 | 0 | 0 | $0 |
| John Lister | General Manager, EMEA | March 9, 2017 M | 84,034 | 0 | 0 | $0 |
| Peter Gerhardsson | VP, Int'l Bus. Dev. | Nov. 16, 2010 P | 3,387 | 0 | 0 | $0 |
| David Carner | VP, Quality Assurance | Aug. 16, 2010 A | — | 0 | 0 | $0 |
| Laura Johnson | V.P., Intellectual Property | March 12, 2010 A | — | 0 | 0 | $0 |
| Richard Yang | V.P., Strategic Affairs | March 12, 2010 A | — | 0 | 0 | $0 |
| Claudia Graham | VP Marketing | March 12, 2010 A | 18,741 | 0 | 0 | $0 |
| Rodney L Kellogg | Vice President of Sales | May 19, 2008 A | — | 0 | 0 | $0 |
| James H Brauker | VP Research & Development | March 24, 2008 A | 53,125 | 0 | 0 | $0 |
| Mark Brister | VP, Advanced Development Team | Nov. 2, 2007 A | 10,967 | 0 | 0 | $0 |
| John Riolo | VP of Quality Assurance | Aug. 2, 2007 A | — | 0 | 0 | $0 |
| Tae Andrews | Vice President of Marketing | March 9, 2007 A | — | 0 | 0 | $0 |
| Mark G Foletta | Director | Aug. 3, 2026 S | 48,852 | 0 | 4 | $-627,183 |
| Albert Frederick Osterloh IV | Director | May 28, 2026 A | 8,691 | 0 | 0 | $0 |
| Euan A. Ashley | Director | May 28, 2026 A | 12,731 | 0 | 0 | $0 |
| Rimma Driscoll | Director | May 28, 2026 A | 17,319 | 0 | 0 | $0 |
| Kyle Malady | Director | May 28, 2026 A | 28,242 | 0 | 1 | $-53,934 |
| Richard Alexander Collins | Director | May 28, 2026 A | 5,605 | 0 | 2 | $-389,410 |
| Renee D Gala | Director | May 28, 2026 A | 12,486 | 0 | 0 | $0 |
| Steven R Altman | Director | May 28, 2026 A | 5,565 | 0 | 0 | $0 |
| Karen M Dahut | Director | May 8, 2025 G | 17,779 | 0 | 0 | $0 |
| Eric Topol | Director | May 8, 2025 G | 380,545 | 0 | 0 | $0 |
| Barbara Kahn | Director | May 18, 2024 G | 22,575 | 0 | 0 | $0 |
| Jay S Skyler | Director | May 18, 2023 G | 63,348 | 0 | 0 | $0 |
| Jonathan T Lord MD | Director | Sept. 1, 2016 S | 52,820 | 0 | 0 | $0 |
| Martin Doordan | Director | June 1, 2012 A | 39,633 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 197 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| TMFM · RBB Fund, Inc. | 5.18% | 81,981 NS | May 31, 2026 | N-PORT |
| HEAL · Global X Funds | 4.89% | 16,599 NS | May 31, 2026 | N-PORT |
| SNSR · Global X Funds | 4.74% | 161,491 NS | May 31, 2026 | N-PORT |
| IHI · iShares Trust | 4.54% | 1,828,483 SH | Aug. 8, 2026 | Daily |
| GDOC · Goldman Sachs ETF Trust | 2.79% | 7,621 NS | May 31, 2026 | N-PORT |
| TMFG · RBB Fund, Inc. | 2.33% | 112,503 NS | May 31, 2026 | N-PORT |
| AGNG · Global X Funds | 2.01% | 22,316 NS | May 31, 2026 | N-PORT |
| HRTS · Tema ETF Trust | 1.92% | 13,512 NS | May 31, 2026 | N-PORT |
| JMID · Janus Detroit Street Trust | 1.91% | 5,848 NS | April 30, 2026 | N-PORT |
| FGSI · First Trust Exchange-Traded Fund IV | 1.89% | 952 NS | April 30, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.72% | 158,549 SH | Aug. 8, 2026 | Daily |
| SPGP · Invesco Exchange-Traded Fund Trust | 1.42% | 389,654 SH | Aug. 8, 2026 | Daily |
| TMFX · RBB Fund, Inc. | 1.37% | 5,955 NS | May 31, 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1.18% | 6,533 NS | May 31, 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1.17% | 15,853 NS | May 31, 2026 | N-PORT |
| DTEC · ALPS ETF Trust | 1.01% | 10,206 NS | May 31, 2026 | N-PORT |
| QGRO · AMERICAN CENTURY ETF TRUST | 1.01% | 302,231 NS | May 31, 2026 | N-PORT |
| LGRO · ALPS ETF Trust | 1.00% | 18,376 NS | May 31, 2026 | N-PORT |
| QQQG · Pacer Funds Trust | 0.99% | 1,867 NS | April 30, 2026 | N-PORT |
| AGRW · ALLSPRING EXCHANGE-TRADED FUNDS TRU… | 0.97% | 17,329 NS | April 30, 2026 | N-PORT |
| RILA · Spinnaker ETF Series | 0.92% | 6,459 NS | April 30, 2026 | N-PORT |
| MMID · MFS Active Exchange Traded Funds Tr… | 0.91% | 4,208 NS | May 31, 2026 | N-PORT |
| IWP · iShares Trust | 0.91% | 2,217,346 SH | Aug. 8, 2026 | Daily |
| SDG · iShares Trust | 0.87% | 18,232 SH | Aug. 8, 2026 | Daily |
| MEDI · Harbor ETF Trust | 0.84% | 3,888 NS | April 30, 2026 | N-PORT |
| QQQE · Direxion Shares ETF Trust | 0.80% | 163,528 NS | April 30, 2026 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0.76% | 296,418 NS | May 31, 2026 | N-PORT |
| AVMV · AMERICAN CENTURY ETF TRUST | 0.67% | 56,679 NS | May 31, 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0.64% | 1,196 NS | April 30, 2026 | N-PORT |
| QNXT · iShares Trust | 0.59% | 2,014 SH | Aug. 8, 2026 | Daily |
| VOT · VANGUARD INDEX FUNDS | 0.57% | 2,956,203 SH | Aug. 8, 2026 | Daily |
| IYH · iShares Trust | 0.52% | 229,458 SH | Aug. 8, 2026 | Daily |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0.46% | 1,074,035 SH | Aug. 8, 2026 | Daily |
| IMCG · iShares Trust | 0.43% | 209,424 SH | Aug. 8, 2026 | Daily |
| RXL · ProShares Trust | 0.41% | 4,013 NS | May 31, 2026 | N-PORT |
| QIDX · Spinnaker ETF Series | 0.41% | 2,617 NS | April 30, 2026 | N-PORT |
| IXJ · iShares Trust | 0.40% | 202,443 SH | Aug. 8, 2026 | Daily |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.38% | 56,496 NS | April 30, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.38% | 1,156,710 SH | Aug. 8, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.38% | 179,798 NS | April 30, 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0.34% | 23,742 SH | Aug. 8, 2026 | Daily |
| MMLG · First Trust Exchange-Traded Fund VI… | 0.33% | 4,233 NS | May 31, 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.33% | 18,233 NS | May 31, 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.33% | 7,675 NS | April 30, 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0.32% | 11,239 NS | May 31, 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.32% | 9,251 NS | May 31, 2026 | N-PORT |
| AVLV · AMERICAN CENTURY ETF TRUST | 0.32% | 558,304 NS | May 31, 2026 | N-PORT |
| TMFE · RBB Fund, Inc. | 0.32% | 3,671 NS | May 31, 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0.30% | 64,292 NS | April 30, 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0.26% | 7,662 NS | May 31, 2026 | N-PORT |